UPCOMING EVENTS
Successful SMEs go Health Information and Training Workshop at the EuroBIO in Paris
SMEs go Health held its 3rd Information and Training Workshop in Paris, France, on 7 October 2008 at the occasion of EuroBiO – the life sciences event of the EU French presidency.
The successful training day attracted over 120 European and international representatives from academia, SMEs and other institutions, ranging from "FP7 new-comers" to experienced proposal writers. The audience was rewarded with an excellent one-day programme fully packed with high-quality information and first-hand tips provided by the European Commission and other experts in the field with real life experiences such as project coordinators, evaluators and National Contact Points.
The presentations offered a broad overview on the 7th Framework Programme and the Health theme as they contained information on successful proposal preparation, evaluation procedures, success stories and upcoming initiatives in the area of Health. Especially the real-life experiences of SMEs and academia in the FP-projects were appreciated by the audience.
Organisers, speakers and participants likewise were very satisfied with the workshop. For all those who could not participate or would like information about the event, the programme and the presentations in pdf format are available for download on the project’s website.

OPEN CALLS & PARTNER SEARCHES
Reminder: Two calls in the area of Health currently open
On 3rd September 2008, the European Commission has published a number calls for proposals under the Seventh Framework Programme (FP7). These include two calls addressing Health, FP7-Health-2009-single-stage (see Call fiche with topics here) and FP7-Health-2009-two-stage (see Call fiche with topics here), both having the deadline on 3rd December 2008. Detailed call documents can be found on the Cordis website.
If you are still looking for partners for your consortium or wish to offer your expertise to an existing group, the SMEs go Health database is THE tool to use! The free-of-charge database offers you an opportunity to explore among 93 existing partner searches and 1900 profiles – have a look, launch your own search and improve your chances for participating in a successful proposal!
OTHER PROJECTS
The ERA-Net EUROTRANS-BIO’s 4th Transnational Call will be launched
on 7 January 2009 - Deadline: 27 April 2009
EUROTRANS-BIO (ETB) is an initiative co-funded by the European Commission involving 11 European countries and regions working together to coordinate their national or regional public funding programmes in order to stimulate international R&D co-operation between Small and Medium-sized Enterprises (SME’s). Its goal is to encourage biotech SMEs to share risks, costs and skills related to innovation. Although SMEs form the main target, universities and research institutes as well as large companies are eligible as partners.
It is an objective of ETB to establish cross-border partnerships between SMEs in the biotech sector to improve and accelerate transnational technology transfer, to strengthen the European efforts to achieve sustainable development, to develop an internal market for research & technology and to develop an efficient joint European research policy.
Eurreca, a network for excellence on micronutrients - with special
attention to SMEs
Source : Eurreca SME group
Vitamins and minerals are familiar to most people in Europe. While the diet is generally adequate, some vulnerable groups may need extra steps to achieve adequate intakes. SMEs can help through the food they produce or the technical instruments they bring to the market.
EURRECA: providing the foundation of micronutrient recommendations
EURRECA is a Network of Excellence whose members are scientists, nutrition companies, consumer organisations, small & medium-sized enterprises and wider stakeholders, funded by the European Commission (EC) to work together to address the problem of national variations in micronutrient recommendations. The Network is made up of 34 partners based in 17 countries. The aim of EURRECA is to produce Europe-wide scientific consensus on the evidence on which micronutrient (vitamin and mineral) recommendations can be developed and applied – including applications by Small and Medium Enterprises (SMEs).
EURRECA’s SME group
EURRECA has created an almost unique dedicated SME group (composed of SMEs and academics) whose core business is transferring knowledge from EURRECA to European SMEs – through various activities including our SME Associate Network. As a consequence, European SMEs should receive from EURRECA insights that will give a global competitive advantage. The industry sectors that the EURRECA SME group targets are food producers, laboratories, companies with an interest in nutrigenomics and nutrition software producers.

NEW! SPOTLIGHT ON RESEARCH PROFILES
Health research excellence in the spotlight : Latvia
Latvia is in the focus of the first of a series of SMEs go Health newsletter articles presenting key research and innovation actors in the "Health" area of European Member States, Associated Countries and Candidate Countries. We invite you to learn more about the expertise of potential new partners for your FP7 projects!

TIPS & TRICKS TO TAKE PART IN FP7
What are the benefits of a two-stage submission?
Last September, the third Health call has been launched and for the first time the two-stage submission procedure will be applied on certain health topics. Only large-scale integrating projects are concerned. The procedure has been introduced to lower the administrative burden and related costs for potential participants.
A two-stage submission procedure means that a detailed application will not have to be submitted until a first assessment of the likely benefits has been made. This will be done on the basis of a limited set of information that has to be submitted only by the coordinator.

SUCCESS STORIES / QUOTES FROM CLIENTS
Large SME participation in the first two FP7 Calls in 2007
Preliminary figures from the output of the first two Calls for proposals published in 2007 (with deadlines in April and September 07) show a quite large and promising SME participation in the Framework Programme. Numbers on SME participation in the first two FP7 health calls presented in the table of the previous SGH newsletter were based on preliminary data. Updated numbers will be provided soon.
Innovative Medicines Initiative (IMI)
Outcome of the first stage of Call 1
The first call for Expressions of Interest (EoI) launched by the Innovative Medicines Initiative (IMI) in April 2008 was met with high response from the European research community: 138 Expressions of interest were submitted for 18 Topics, addressing 3 of the 4 IMI "pillars", namely Safety, Efficacy, and Education and Training. According to the IMI Joint Undertaking, all topics have been adequately covered by the EoIs received, rendering the first stage of the first IMI Call with a budget of around 294 Mio Euro a success.
Altogether, more than 1200 Teams were involved in the EoIs, 17 % thereof stemming from SMEs, 77 % from academic institutions, and the remaining percentages consisting of patient organisations, regulatory agencies, industry associations and large "non-EFPIA" companies.

SMEs’ Advice
“I would like to highlight once again the significance of the “SMEs go Health” database and thank you for your efforts, since this collaboration has been established due to this database”.
Proposal: NANOBIOS: "Nanochemistry for Bioseparation and Sensing"
Marie Curie Initial Training Networks (ITN) proposal
Name: Dr. Antreas AFANTITIS
NovaMechanics Ltd - Cyprus
Newsletter by EuroTop. |